Vontier (VNT) Competitors $38.08 -0.86 (-2.21%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends VNT vs. TER, AVTR, RVTY, BIO.B, NVMI, ST, MIR, TRNS, CTKB, and LABShould you be buying Vontier stock or one of its competitors? The main competitors of Vontier include Teradyne (TER), Avantor (AVTR), Revvity (RVTY), Bio-Rad Laboratories (BIO.B), Nova (NVMI), Sensata Technologies (ST), Mirion Technologies (MIR), Transcat (TRNS), Cytek Biosciences (CTKB), and Standard BioTools (LAB). These companies are all part of the "measuring and control equipment" industry. Vontier vs. Teradyne Avantor Revvity Bio-Rad Laboratories Nova Sensata Technologies Mirion Technologies Transcat Cytek Biosciences Standard BioTools Vontier (NYSE:VNT) and Teradyne (NASDAQ:TER) are both business services companies, but which is the better stock? We will compare the two companies based on the strength of their community ranking, dividends, valuation, analyst recommendations, profitability, risk, media sentiment, earnings and institutional ownership. Is VNT or TER a better dividend stock? Vontier pays an annual dividend of $0.10 per share and has a dividend yield of 0.3%. Teradyne pays an annual dividend of $0.48 per share and has a dividend yield of 0.5%. Vontier pays out 3.8% of its earnings in the form of a dividend. Teradyne pays out 15.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Is VNT or TER more profitable? Teradyne has a net margin of 18.75% compared to Vontier's net margin of 13.54%. Vontier's return on equity of 45.48% beat Teradyne's return on equity.Company Net Margins Return on Equity Return on Assets Vontier13.54% 45.48% 10.49% Teradyne 18.75%18.56%13.91% Do institutionals & insiders have more ownership in VNT or TER? 95.8% of Vontier shares are held by institutional investors. Comparatively, 99.8% of Teradyne shares are held by institutional investors. 0.8% of Vontier shares are held by company insiders. Comparatively, 0.4% of Teradyne shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has more risk & volatility, VNT or TER? Vontier has a beta of 1.25, meaning that its stock price is 25% more volatile than the S&P 500. Comparatively, Teradyne has a beta of 1.52, meaning that its stock price is 52% more volatile than the S&P 500. Which has stronger valuation & earnings, VNT or TER? Teradyne has lower revenue, but higher earnings than Vontier. Vontier is trading at a lower price-to-earnings ratio than Teradyne, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVontier$3.10B1.85$376.90M$2.6114.59Teradyne$2.74B6.10$448.75M$3.1532.57 Does the media favor VNT or TER? In the previous week, Teradyne had 9 more articles in the media than Vontier. MarketBeat recorded 21 mentions for Teradyne and 12 mentions for Vontier. Teradyne's average media sentiment score of 1.21 beat Vontier's score of 1.16 indicating that Teradyne is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vontier 8 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Teradyne 12 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor VNT or TER? Teradyne received 30 more outperform votes than Vontier when rated by MarketBeat users. However, 48.72% of users gave Vontier an outperform vote while only 43.87% of users gave Teradyne an outperform vote. CompanyUnderperformOutperformVontierOutperform Votes3848.72% Underperform Votes4051.28% TeradyneOutperform Votes6843.87% Underperform Votes8756.13% Do analysts recommend VNT or TER? Vontier currently has a consensus price target of $44.50, suggesting a potential upside of 16.86%. Teradyne has a consensus price target of $142.62, suggesting a potential upside of 39.03%. Given Teradyne's higher possible upside, analysts plainly believe Teradyne is more favorable than Vontier.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vontier 0 Sell rating(s) 3 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.63Teradyne 1 Sell rating(s) 5 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.50 SummaryTeradyne beats Vontier on 14 of the 20 factors compared between the two stocks. Ad Paradigm Press[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.Click here now for the urgent details on this hidden play. Get Vontier News Delivered to You Automatically Sign up to receive the latest news and ratings for VNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VNT vs. The Competition Export to ExcelMetricVontierFluid meters & counting devices IndustryBusiness SectorNYSE ExchangeMarket Cap$5.72B$6.03B$7.16B$19.82BDividend Yield0.26%0.44%2.33%3.50%P/E Ratio14.5934.0126.4442.32Price / Sales1.854.86169.6020.76Price / Cash10.3532.3728.0021.65Price / Book5.488.104.804.66Net Income$376.90M$234.75M$120.67M$983.45M7 Day Performance-4.92%-4.28%10.25%-2.12%1 Month Performance10.50%4.28%12.59%-0.47%1 Year Performance12.80%29.08%35.78%24.69% Vontier Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VNTVontier3.7837 of 5 stars$38.08-2.2%$44.50+16.9%+12.8%$5.72B$3.10B14.598,000Positive NewsTERTeradyne4.9966 of 5 stars$107.18+0.8%N/A+13.0%$17.46B$2.68B34.036,500Dividend AnnouncementBuyback AnnouncementAnalyst RevisionPositive NewsGap DownAVTRAvantor4.9809 of 5 stars$21.31-1.3%N/A+7.5%$14.50B$6.82B46.3314,500Options VolumeAnalyst RevisionPositive NewsRVTYRevvity3.9523 of 5 stars$117.25-2.1%N/A+24.2%$14.27B$2.75B56.6411,500Positive NewsBIO.BBio-Rad LaboratoriesN/A$334.85flatN/A+11.6%$9.38B$2.67B-12.258,200NVMINova4.3568 of 5 stars$191.09+0.9%N/A+48.5%$5.55B$517.92M35.653,606Positive NewsGap DownSTSensata Technologies4.8814 of 5 stars$33.01+1.0%N/A-2.6%$4.94B$4.05B-61.1319,400Short Interest ↓Positive NewsMIRMirion Technologies1.3569 of 5 stars$15.15+0.7%N/A+79.0%$3.52B$800.90M-44.563,000Options VolumeTRNSTranscat3.2647 of 5 stars$110.37+2.4%N/A+14.3%$1.02B$259.48M55.741,104News CoveragePositive NewsCTKBCytek Biosciences3.3399 of 5 stars$6.43-5.2%N/A+1.4%$828.25M$193.01M-80.36500Short Interest ↓Positive NewsLABStandard BioTools3.4395 of 5 stars$1.77-4.1%N/A-28.2%$657.04M$106.34M-2.49620Positive News Related Companies and Tools Related Companies Teradyne Competitors Avantor Competitors Revvity Competitors Bio-Rad Laboratories Competitors Nova Competitors Sensata Technologies Competitors Mirion Technologies Competitors Transcat Competitors Cytek Biosciences Competitors Standard BioTools Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:VNT) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vontier Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vontier With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.